Skip to main content
. 2019 Feb;36(Suppl 1):S22–S26.

TABLE 2.

Zoledronic Acid Dosing

Variables Interval

Standard (n = 121) Extended (n = 35)
No. doses, mean (SD) 11.4 (13.5) 5.9 (3.18)

Discontinued, No. (%) 121 (100) 21 (60)

Reason for discontinuation, No. (%)
 Adverse reaction 3 (3) 0 (0)
 Treatment failure (skeletal-related event) 1 (1) 0 (0)
 Dosing interval change 13 (11) 2 (10)
 Changed to pamidronate 7 (6) 1 (5)
 Death 25 (21) 0 (0)
 Patient/physician choice 12 (10) 3 (14.3)
 Unknown 61 (50) 16 (76)